Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
UBS
Fuji
Medtronic
Cantor Fitzgerald
Teva
Colorcon
Baxter
US Department of Justice

Generated: January 19, 2018

DrugPatentWatch Database Preview

Claims for Patent: 6,114,144

« Back to Dashboard

Summary for Patent: 6,114,144
Title: Isolation of a gene encoding human thyrotropin .beta. subunit
Abstract:The gene expressing the .beta. subunit of human thyroid stimulating hormone has been isolated. The gene has been incorporated into plasmid pBR322. Vectors can be used to transform cells which in turn produce pure .beta. subunits. The .beta. subunits can then be combined with the alpha subunit of human glycoprotein hormones to produce pure thyroid stimulating hormone.
Inventor(s): Kourides; Ione A. (Forest Hills, NY), Whitfield; Graham Kerr (New York, NY)
Assignee: Sloan-Kettering Institute for Cancer Research (New York, NY)
Application Number:08/957,545
Patent Claims: 1. A method for producing the .beta. subunit of human thyroid stimulating hormone comprising:

(a) transforming cells with a vector containing DNA encoding the .beta. subunit of human thyroid stimulating hormone and culturing said cells under conditions suitable for expression of the .beta. subunit of human thyroid stimulating hormone; and

(b) recovering the .beta. subunit of human thyroid stimulating hormone so produced.

2. The method of claim 1, wherein the DNA comprises the below sequence:

3. The method of claim 1, wherein the DNA comprises the below sequence:

4. The method of claim 1, wherein the DNA comprises the below sequence:

5. The method of claim 1, wherein the vector is a plasmid.

6. The method of claim 1, wherein the vector is a virus.

7. The method of claim 1, wherein the cell is a prokaryote.

8. The method of claim 1, wherein the cell is a eukaryote.

9. The method of claim 7, wherein the prokaryote is a bacterium.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Citi
AstraZeneca
Accenture
Moodys
Boehringer Ingelheim
Fish and Richardson
Julphar
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot